| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 24, 2009
Accepted on September 14, 2009
Laboratory of Molecular Genetics and Howard Hughes Medical Institute (T.A., C.A.P., J.M.F.), Rockefeller University, New York, New York 10065; Department of Pharmacology (L.Z., A.S.G., L.K.H.), University of Cambridge, Cambridge CB2 1PD, United Kingdom; and Department of Obstetrics and Gynecology (T.A.), New York University Medical Center, New York, New York 10016
* To whom correspondence should be addressed. E-mail: friedj{at}rockefeller.edu or lkh30{at}cam.ac.uk.
CRH is widely expressed in the brain and is of broad functional relevance to a number of physiological processes, including stress response, parturition, immune response, and ingestive behavior. To delineate further the organization of the central CRH network, we generated mice expressing green fluorescent protein (GFP) under the control of the CRH promoter, using bacterial artificial chromosome technology. Here we validate CRH-GFP transgene expression within specific brain regions and confirm the distribution of central GFP-producing cells to faithfully recapitulate that of CRH-expressing cells. Furthermore, we confirm the functional integrity of a population of GFP-producing cells by demonstrating their apposite responsiveness to nutritional status. We anticipate that this transgenic model will lend itself as a highly tractable tool for the investigation of CRH expression and function in discrete brain regions.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |